SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-420974
Filing Date
2012-10-11
Accepted
2012-10-11 16:01:40
Documents
5
Period of Report
2012-10-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d423498d8k.htm 8-K 36000
2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF REGULUS THERAPEUTICS INC. d423498dex31.htm EX-3.1 25189
3 AMENDED AND RESTATED BYLAWS OF REGULUS THERAPEUTICS INC. d423498dex32.htm EX-3.2 118203
4 INVESTOR RIGHTS AGREEMENT d423498dex101.htm EX-10.1 85172
5 CONVERTIBLE PROMISSORY NOTE d423498dex102.htm EX-10.2 55194
  Complete submission text file 0001193125-12-420974.txt   321053
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 121140067
SIC: 2834 Pharmaceutical Preparations